Condition: Coronary Artery Disease · Restenoses, Coronary · Sponsor: Deutsches Herzzentrum Muenchen
The hypothesis of the study is, that there is a significant interaction in treatment effect between the OCT pattern of neointima (heterogeneous or homogeneous) and the type of percutaneous coronary intervention (drug-eluting stent or drug-coated balloon) in patients with in-stent restenosis.
This description comes directly from the study's public registry record.
Felix Voll, MD · +49 89 1218 2749 · voll@dhm.mhn.de
Salvatore Cassese, MD, PHD · +49 89 1218 2764 · cassese@dhm.mhn.de
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Frankfurt | Frankfurt am Main, Hesse, Germany | Recruiting |
| Elisabeth-Krankenhaus Essen GmbH | Essen, Germany | Recruiting |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg, Germany | Recruiting |
| Deutsches Herzzentrum München | Munich, Germany | Recruiting |
| Hospital Universitario de La Princesa Madrid | Madrid, Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05544864